CHICAGO (Reuters) - U.S. health authorities added Merck & Co. Inc.'s new vaccine for cervical cancer to a government-subsidized vaccine program for schoolchildren, helping to expand its availability, the company said on Wednesday.
CHICAGO (Reuters) - U.S. health authorities added Merck & Co. Inc.'s new vaccine for cervical cancer to a government-subsidized vaccine program for schoolchildren, helping to expand its availability, the company said on Wednesday.
